Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Direct comparison of prognostic ability of cardiac biomarkers for cardiogenic stroke and clinical outcome in patients with stroke.

Otaki Y, Watanabe T, Sato N, Shirata T, Tsuchiya H, Wanezaki M, Tamura H, Nishiyama S, Arimoto T, Takahashi H, Shishido T, Morikane K, Watanabe M.

Heart Vessels. 2019 Jul;34(7):1178-1186. doi: 10.1007/s00380-019-01345-w. Epub 2019 Jan 17.

PMID:
30656414
2.

Complete remission in a bleeding patient with idiopathic autoimmune factor X deficiency caused by non-neutralizing anti-factor X autoantibody.

Mori M, Mochizuki K, Souri M, Nakamura Y, Tokuman N, Kanouchi K, Morikane K, Ichinose A.

Haemophilia. 2019 Mar;25(2):e106-e109. doi: 10.1111/hae.13675. Epub 2018 Dec 20. No abstract available.

PMID:
30570186
3.

A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis.

Ogawa H, Souri M, Kanouchi K, Osaki T, Ohkubo R, Kawanishi T, Wakai S, Morikane K, Ichinose A.

Int J Hematol. 2019 Feb;109(2):214-220. doi: 10.1007/s12185-018-2561-9. Epub 2018 Nov 16.

PMID:
30446942
4.

Epidemiology and risk factors associated with surgical site infection following surgery on thoracic aorta.

Morikane K.

Epidemiol Infect. 2018 Oct;146(14):1841-1844. doi: 10.1017/S0950268818001930. Epub 2018 Jul 11.

PMID:
29991367
5.

Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.

Kanouchi K, Narimatsu H, Ohnuma O, Morikane K, Fukao A.

Int J Hematol. 2017 Aug;106(2):206-211. doi: 10.1007/s12185-017-2228-y. Epub 2017 Apr 7.

PMID:
28390037
6.

Epidemiology and risk factors associated with surgical site infection after different types of hepatobiliary and pancreatic surgery.

Morikane K.

Surg Today. 2017 Oct;47(10):1208-1214. doi: 10.1007/s00595-017-1503-0. Epub 2017 Mar 16.

PMID:
28303341
7.

[Risk Factor Analysis of Pneumonia after Cardiovascular Surgery].

Maekawa Y, Abe S, Nakamura K, Uchida T, Sadahiro M, Morikane K.

Kyobu Geka. 2016 Aug;69(9):731-8. Japanese.

PMID:
27476560
8.

Factors Associated With Surgical Site Infection Following Gastric Surgery in Japan.

Morikane K, Honda H, Suzuki S.

Infect Control Hosp Epidemiol. 2016 Oct;37(10):1167-72. doi: 10.1017/ice.2016.155. Epub 2016 Jul 19.

PMID:
27430979
9.

APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI).

Ling ML, Apisarnthanarak A, Jaggi N, Harrington G, Morikane K, Thu le TA, Ching P, Villanueva V, Zong Z, Jeong JS, Lee CM.

Antimicrob Resist Infect Control. 2016 May 4;5:16. doi: 10.1186/s13756-016-0116-5. eCollection 2016. Review.

10.
12.

Differences in risk factors associated with surgical site infections following two types of cardiac surgery in Japanese patients.

Morikane K, Honda H, Yamagishi T, Suzuki S.

J Hosp Infect. 2015 May;90(1):15-21. doi: 10.1016/j.jhin.2014.11.022. Epub 2015 Jan 7.

PMID:
25623210
13.

[Clinical characteristics of biliary tract infection and acalculous cholecystitis after cardiovascular surgery].

Maekawa Y, Abe S, Yoshimura Y, Uchida T, Kim C, Kuroda Y, Mizumoto M, Sadahiro M, Morikane K.

Kyobu Geka. 2014 Nov;67(12):1039-43; discussion 1043-6. Japanese.

PMID:
25391463
14.
15.

[Procalcitonin as a marker of the postoperative infection in cardiovascular surgery].

Maekawa Y, Abe S, Yoshimura Y, Uchida T, Kim C, Kuroda Y, Mizumoto M, Sadahiro M, Morikane K.

Kyobu Geka. 2014 Jul;67(7):519-23; discussion 523-5. Japanese.

PMID:
25137316
16.

Factors associated with surgical site infection in colorectal surgery: the Japan nosocomial infections surveillance.

Morikane K, Honda H, Yamagishi T, Suzuki S, Aminaka M.

Infect Control Hosp Epidemiol. 2014 Jun;35(6):660-6. doi: 10.1086/676438. Epub 2014 Apr 22.

PMID:
24799642
17.

Toward the rational use of standardized infection ratios to benchmark surgical site infections.

Fukuda H, Morikane K, Kuroki M, Taniguchi S, Shinzato T, Sakamoto F, Okada K, Matsukawa H, Ieiri Y, Hayashi K, Kawai S.

Am J Infect Control. 2013 Sep;41(9):810-4. doi: 10.1016/j.ajic.2012.10.004. Epub 2013 Feb 1.

PMID:
23375577
18.

Impact of surgical site infections after open and laparoscopic colon and rectal surgeries on postoperative resource consumption.

Fukuda H, Morikane K, Kuroki M, Kawai S, Hayashi K, Ieiri Y, Matsukawa H, Okada K, Sakamoto F, Shinzato T, Taniguchi S.

Infection. 2012 Dec;40(6):649-59. doi: 10.1007/s15010-012-0317-7. Epub 2012 Aug 23.

PMID:
22915346
19.

[Management of infectious diseases and the role of Infection Control Team(ICT) in the cancer treatment].

Morikane K.

Gan To Kagaku Ryoho. 2012 Feb;39(2):158-61. Japanese.

PMID:
22333624
20.

Infection control in healthcare settings in Japan.

Morikane K.

J Epidemiol. 2012;22(2):86-90. Epub 2012 Feb 4. Review.

21.

[Pandemic influenza].

Morikane K.

Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2012;23(1):19-22. Japanese. No abstract available.

PMID:
23547481
22.

Maximal sterile barrier precautions do not reduce catheter-related bloodstream infections in general surgery units.

Morikane K.

Ann Surg. 2011 Jun;253(6):1234-5; author reply 1235. No abstract available.

PMID:
21739642
23.

A norovirus outbreak associated with environmental contamination at a hotel.

Kimura H, Nagano K, Kimura N, Shimizu M, Ueno Y, Morikane K, Okabe N.

Epidemiol Infect. 2011 Feb;139(2):317-25. doi: 10.1017/S0950268810000981. Epub 2010 Apr 30.

PMID:
20429969
24.

[Changing management of pandemic influenza].

Morikane K.

Rinsho Byori. 2010 Mar;58(3):254-62. Review. Japanese.

PMID:
20408444
25.

Comparative analysis of Micrococcus luteus isolates from blood cultures of patients with pulmonary hypertension receiving epoprostenol continuous infusion.

Hirata Y, Sata M, Makiuchi Y, Morikane K, Wada A, Okabe N, Tomoike H.

J Infect Chemother. 2009 Dec;15(6):424-5. doi: 10.1007/s10156-009-0720-x.

PMID:
20012737
26.

[Western guidelines on the prevention of postoperative infections and compliance].

Morikane K.

Nihon Geka Gakkai Zasshi. 2006 Sep;107(5):207-10. Japanese.

PMID:
17017414
27.

Prospective surveillance effectively reduced rates of surgical site infection associated with elective colorectal surgery at a university hospital in Japan.

Konishi T, Watanabe T, Morikane K, Fukatsu K, Kitayama J, Umetani N, Kishimoto J, Nagawa H.

Infect Control Hosp Epidemiol. 2006 May;27(5):526-8. Epub 2006 Apr 20.

PMID:
16671040
28.

The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis.

Moniaux N, Nemos C, Schmied BM, Chauhan SC, Deb S, Morikane K, Choudhury A, Vanlith M, Sutherlin M, Sikela JM, Hollingsworth MA, Batra SK.

Oncogene. 2006 Jun 1;25(23):3247-57. Epub 2006 Feb 20.

PMID:
16491129
29.

Cancer-derived VEGF plays no role in malignant ascites formation in the mouse.

Guleng B, Tateishi K, Kanai F, Jazag A, Ohta M, Asaoka Y, Ijichi H, Tanaka Y, Imamura J, Ikenoue T, Fukushima Y, Morikane K, Miyagishi M, Taira K, Kawabe T, Omata M.

World J Gastroenterol. 2005 Sep 21;11(35):5455-9.

30.

Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.

Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, Kawabe T, Miyagishi M, Taira K, Sata M, Omata M.

Cancer Res. 2005 Jul 1;65(13):5864-71.

31.

[Surgical site infection surveillance].

Konishi T, Harihara Y, Morikane K.

Nihon Geka Gakkai Zasshi. 2004 Nov;105(11):720-5. Review. Japanese.

PMID:
15565904
32.

Characteristic features of abdominal organ injuries associated with gastric rupture in blunt abdominal trauma.

Shinkawa H, Yasuhara H, Naka S, Morikane K, Furuya Y, Niwa H, Kikuchi T.

Am J Surg. 2004 Mar;187(3):394-7.

PMID:
15006569
33.

Using surveillance data to direct infection control efforts to reduce surgical-site infections following clean abdominal operations in Japan.

Morikane K, Nishioka M, Tanimura H, Noguchi H, Konishi T, Kobayashi H.

Infect Control Hosp Epidemiol. 2002 Jul;23(7):404-6.

PMID:
12138982
34.

Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines.

Sivinski CL, Kohlgraf KG, VanLith ML, Morikane K, Tempero RM, Hollingsworth MA.

Cancer Immunol Immunother. 2002 Aug;51(6):327-40. Epub 2002 May 4.

PMID:
12111121
35.

Influence of organ site and tumor cell type on MUC1-specific tumor immunity.

Morikane K, Tempero R, Sivinski CL, Kitajima S, Gendler SJ, Hollingsworth MA.

Int Immunol. 2001 Feb;13(2):233-40.

PMID:
11157856
36.

Organ-specific pancreatic tumor growth properties and tumor immunity.

Morikane K, Tempero RM, Sivinski CL, Nomoto M, Van Lith ML, Muto T, Hollingsworth MA.

Cancer Immunol Immunother. 1999 Jan;47(5):287-96.

PMID:
10022473
37.

CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice.

Tempero RM, VanLith ML, Morikane K, Rowse GJ, Gendler SJ, Hollingsworth MA.

J Immunol. 1998 Nov 15;161(10):5500-6.

38.

Histologic and biologic patterns of microscopic pancreatic ductal adenocarcinomas detected incidentally at autopsy.

Kimura W, Morikane K, Esaki Y, Chan WC, Pour PM.

Cancer. 1998 May 15;82(10):1839-49.

PMID:
9587115
39.

A small glucagonoma of the pancreas with evident ductular and tubular structures.

Morikane K, Kimura W, Inoue S, Muto T.

J Gastroenterol. 1997 Aug;32(4):562-5.

PMID:
9250909
40.

A new method of duodenum-preserving subtotal resection of the head of the pancreas based on the surgical anatomy.

Kimura W, Morikane K, Futakawa N, Shinkai H, Han I, Inoue T, Muto T, Nagai H.

Hepatogastroenterology. 1996 Mar-Apr;43(8):463-72.

PMID:
8714245

Supplemental Content

Loading ...
Support Center